How many institutions held CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 in Q1 2022?

157 institutional investors reported CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 for Q1 2022. Use the holders table for investor-level position and value details.

Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)

Q: What does CUSIP 15117B202 represent in this 13F holders report?

CUSIP 15117B202 is the security identifier for CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 used to aggregate holder disclosures.

CUSIP: 15117B202

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Common Stock, par value $0.001
Total 13F shares: 49,602,527
Total 13F value: $1,689,417,077
Share change: +3,335,239
Put/Call ratio: 64%
SEC-reported price per share: $34.06
Number of holders: 157
Value change: +$106,143,717
Number of buys: 80
Number of sells: 75
Shares outstanding: 78,103,117

Security key

15117B202

Report period

Q1 2022

Institutions

157

Top holders

CLDX full security history Ownership snapshot Full 13F holder table Celldex Therapeutics, Inc. SEC filings Celldex Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 9% Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Comparable ownership Top 5

FMR LLC 9%

RTW INVESTMENTS, LP 5%

BlackRock Finance, Inc. 4%

VANGUARD GROUP INC 3.1%

STATE STREET CORP 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F Company 13F	9%	$270,464,000 6,999,580 shares	—	31 Dec 2021
RTW INVESTMENTS, LP	13F Company 13F	5%	$151,530,000 3,921,579 shares	—	31 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	4%	$119,823,000 3,101,030 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	3.1%	$93,240,000 2,413,056 shares	—	31 Dec 2021
STATE STREET CORP	13F Company 13F	3%	$91,501,000 2,368,040 shares	—	31 Dec 2021
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	2.8%	$84,468,000 2,185,976 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

157

49,602,527

Rows available

157

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

157

Q1 2022 holders

157

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %